Journal
NUCLEIC ACIDS RESEARCH
Volume 46, Issue 8, Pages 3878-3890Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gky127
Keywords
-
Categories
Funding
- Cancer Research UK [C1443/A22095]
- Biotechnology and Biological Sciences Research Council Doctoral Training Partnership Studentship
- Biotechnology and Biological Sciences Research Council [BB/M018318/1]
- Newcastle University Independent Researcher Establishment Scheme Award
- Newcastle University
- BBSRC [BB/M018318/1] Funding Source: UKRI
Ask authors/readers for more resources
HIF1 alpha (hypoxia inducible factor 1 alpha) is the central regulator of the cellular response to low oxygen and its activity is deregulated in multiple human pathologies. Consequently, given the importance of HIF signaling in disease, there is considerable interest in developing strategies to modulate HIF1 alpha activity and down-stream signaling events. In the present study we find that under hypoxic conditions, activation of the PERK branch of the unfolded protein response (UPR) can suppress the levels and activity of HIF1 alpha by preventing efficient HIF1 alpha translation. Activation of PERK inhibits de novo HIF1 alpha protein synthesis by preventing the RNA-binding protein, YB-1, from interacting with the HIF1 alpha mRNA 5'UTR. Our data indicate that activation of the UPR can sensitise tumor cells to hypoxic stress, indicating that chemical activation of the UPR could be a strategy to target hypoxic malignant cancer cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available